219 related articles for article (PubMed ID: 22226840)
1. Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor.
Zaheer S; Wu Y; Yang X; Ahrens M; Sahu SK; Zaheer A
Neurochem Int; 2012 Feb; 60(3):215-9. PubMed ID: 22226840
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice.
Zaheer S; Wu Y; Sahu SK; Zaheer A
Neurobiol Dis; 2010 Dec; 40(3):593-8. PubMed ID: 20696246
[TBL] [Abstract][Full Text] [Related]
3. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
4. Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody.
Zaheer S; Wu Y; Sahu SK; Zaheer A
Brain Res; 2011 Feb; 1373():230-9. PubMed ID: 21146509
[TBL] [Abstract][Full Text] [Related]
5. Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis.
Zaheer S; Wu Y; Bassett J; Yang B; Zaheer A
Neurochem Res; 2007 Dec; 32(12):2123-31. PubMed ID: 17551829
[TBL] [Abstract][Full Text] [Related]
6. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
[TBL] [Abstract][Full Text] [Related]
7. Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice.
Menon K; Wu Y; Haas J; Sahu SK; Yang B; Zaheer A
Neurosci Res; 2007 Jun; 58(2):156-63. PubMed ID: 17383764
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
9. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
Lyons JA; Ramsbottom MJ; Cross AH
Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
[TBL] [Abstract][Full Text] [Related]
10. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
Oliver AR; Lyon GM; Ruddle NH
J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
[TBL] [Abstract][Full Text] [Related]
11. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis.
Okuda Y; Sakoda S; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T
J Neuroimmunol; 1999 Nov; 101(2):188-96. PubMed ID: 10580801
[TBL] [Abstract][Full Text] [Related]
12. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination.
Gran B; Zhang GX; Yu S; Li J; Chen XH; Ventura ES; Kamoun M; Rostami A
J Immunol; 2002 Dec; 169(12):7104-10. PubMed ID: 12471147
[TBL] [Abstract][Full Text] [Related]
13. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
14. Reduced severity of experimental autoimmune encephalomyelitis in GMF-deficient mice.
Zaheer A; Zaheer S; Sahu SK; Yang B; Lim R
Neurochem Res; 2007 Jan; 32(1):39-47. PubMed ID: 17151915
[TBL] [Abstract][Full Text] [Related]
15. Increased severity of experimental allergic encephalomyelitis in lyn-/- mice in the absence of elevated proinflammatory cytokine response in the central nervous system.
Du C; Sriram S
J Immunol; 2002 Mar; 168(6):3105-12. PubMed ID: 11884485
[TBL] [Abstract][Full Text] [Related]
16. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
17. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
Vandenbark AA; Rich C; Mooney J; Zamora A; Wang C; Huan J; Fugger L; Offner H; Jones R; Burrows GG
J Immunol; 2003 Jul; 171(1):127-33. PubMed ID: 12816990
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
[TBL] [Abstract][Full Text] [Related]
20. A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice.
Bergman CM; Marta CB; Maric M; Pfeiffer SE; Cresswell P; Ruddle NH
J Immunol; 2012 Jun; 188(12):6001-9. PubMed ID: 22586035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]